“The apprehension with working with non IID outlined ingredients is justified as it can be extremely hard to evaluate if FDA would discover the ‘novel excipient’ safe to be used in a very drug product as there's no outlined system for evaluation and acceptance of excipients. The FDA guidance https://damienlhype.bloggerbags.com/32052839/top-guidelines-of-proleviate-includes-fda-approved-ingredients